“Teneligliptin: DPP-4 inhibitor in the treatment of type II Diabetes Mellitus”, Int J of Phytopharm, vol. 7, no. 4, pp. 30–35, Aug. 2017, doi: 10.7439/ijpp.v7i4.4347.